Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aspartate aminotransferase (AST), also known as aspartate transaminase or SGOT, is a pyridoxal phosphate-dependent enzyme that catalyzes the reversible transfer of an α-amino group between aspartate and glutamate. It is found in high concentrations in the liver, heart, and skeletal muscle, and elevated levels in the blood can indicate damage to these tissues. Measurement of AST levels in blood is primarily used to assess liver health, but may also reflect injury to other tissues. Interpretation of AST levels requires clinical correlation and often additional testing.
Not applicable (AST is an enzyme, not a drug target directly acted upon by drugs; drugs can influence its levels indirectly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspartate Aminotransferase (AST).